利索-全球专利检索

  1. 登录
  2. 注册
发明授权
US06270766B1 Anti-TNF antibodies and methotrexate in the treatment of arthritis and crohn's disease 失效
抗TNF抗体和甲氨蝶呤治疗关节炎和克罗恩病

  • 专利标题： Anti-TNF antibodies and methotrexate in the treatment of arthritis and crohn's disease
  • 专利标题（中）： 抗TNF抗体和甲氨蝶呤治疗关节炎和克罗恩病
  • 申请号： US08690775
    申请日： 1996-08-01
  • 公开(公告)号： US06270766B1
    公开(公告)日： 2001-08-07
  • 发明人: Marc Feldman , Ravinder N. Maini
  • 申请人： Marc Feldman , Ravinder N. Maini
  • 主分类号： A61K39395
  • IPC分类号： A61K39395
Anti-TNF antibodies and methotrexate in the treatment of arthritis and crohn's disease
摘要：
Methods for treating and/or preventing a TNF-mediated disease in an individual are disclosed. Also disclosed is a composition comprising methotrexate and an anti-tumor necrosis factor antibody. TNF-mediated diseases include rheumatoid arthritis, Crohn's disease, and acute and chronic immune diseases associated with transplantation.
摘要（中）：

公开了治疗和/或预防个体中TNF介导的疾病的方法。 还公开了包含甲氨蝶呤和抗肿瘤坏死因子抗体的组合物。 TNF介导的疾病包括类风湿性关节炎，克罗恩病以及与移植相关的急性和慢性免疫疾病。

信息查询
Espacenet
0/0